PF-07225570 Alone or in Combination With an Anti-PD-1 Antibody in Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)
Clinical trial NCT05259397 · WITHDRAWN
Trial details
- NCT number
- NCT05259397
- Sponsor
- Pfizer
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-24
- Primary completion
- 2022-09-19
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.